Charles River Laboratories EPS - Earnings per Share 2010-2024 | CRL

Charles River Laboratories earnings per share (EPS) for the twelve months ending December 31, 2024 was $0.20, a 97.83% decline year-over-year.

  • Charles River Laboratories EPS for the quarter ending December 31, 2024 was $-4.17, a 214.88% decline year-over-year.
  • Charles River Laboratories 2024 annual EPS was $0.2, a 97.83% decline from 2023.
  • Charles River Laboratories 2023 annual EPS was $9.22, a 2.74% decline from 2022.
  • Charles River Laboratories 2022 annual EPS was $9.48, a 24.74% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Charles River Laboratories EPS - Earnings per Share 2010-2024 | CRL

  • Charles River Laboratories EPS for the quarter ending December 31, 2024 was $-4.17, a 214.88% decline year-over-year.
  • Charles River Laboratories 2024 annual EPS was $0.2, a 97.83% decline from 2023.
  • Charles River Laboratories 2023 annual EPS was $9.22, a 2.74% decline from 2022.
  • Charles River Laboratories 2022 annual EPS was $9.48, a 24.74% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$150.2B
Elevance Health (ELV)$90.6B
CVS Health (CVS)$82.1B
Cencora (COR)$47.2B
DiDi Global (DIDIY)$23.3B
Natera (NTRA)$22.2B
ICON (ICLR)$16.7B
BioMerieux (BMXMF)$14.1B
Doximity (DOCS)$14B
Revvity (RVTY)$14B
Viatris (VTRS)$13.2B
Solventum (SOLV)$12.9B
Avantor (AVTR)$11.9B
CochLear (CHEOY)$11.3B
Medpace Holdings (MEDP)$10.5B
EUROFINS SCIENT (ERFSF)$9.8B
HealthEquity (HQY)$9.7B
Sonic Healthcare (SKHHY)$8.7B
Amplifon S.p.A (AMFPF)$6.2B
Bausch + Lomb (BLCO)$5.6B
Organon (OGN)$4B
Sotera Health (SHC)$3.8B
BrightSpring Health Services (BTSG)$3.6B
Surgery Partners (SGRY)$3.3B
Concentras Parent (CON)$3B
GeneDx Holdings (WGS)$2.8B
Alignment Healthcare (ALHC)$2.8B
Teladoc Health (TDOC)$2.2B
Ardent Health Partners (ARDT)$2.1B
Progyny (PGNY)$2B